Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells

Fertility and Sterility

Volumn 85, Issue SUPPL. 1, 2006, Pages 1195-1203

  Chang, Chih Yang ^a,b   Hsuuw, Yan Der ^c   Huang, Fu Jen ^a   Shyr, Chih Rong ^b   Chang, Shiuh Young ^a   Huang, Chiung Kuei ^b   Kang, Hong Yo ^b   Huang, Ko En ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Androgen receptor; dihydrotestosterone; mouse embryonic stem cell; nilutamide; proliferation; testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; MESSENGER RNA; NILUTAMIDE; PROTEIN KINASE B; TESTOSTERONE;

ANDROGENESIS; ANIMAL CELL; ARTICLE; BLASTOCYST; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STIMULATION; COLORIMETRY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INNER CELL MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; WESTERN BLOTTING;

ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; BLASTOCYST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIHYDROTESTOSTERONE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMIDAZOLIDINES; MICE; MICE, INBRED ICR; RECEPTORS, ADRENERGIC; STEM CELLS; TESTOSTERONE;

EID: 33645732074     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.11.031     Document Type: Article

References (38)

1. Gray Jr. L.E., Wolf C., Lambright C., Mann P., Price M., Cooper R.L., et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 15 (1999) 94-118
2. Wolf C.J., Hotchkiss A., Ostby J.S., LeBlanc G.A., and Gray Jr. L.E. Effects of prenatal testosterone propionate on the sexual development of male and female rats. a dose-response study. Toxicol Sci 65 (2002) 71-86
3. Yun Y.W., Yuen B.H., and Moon Y.S. Effects of an antiandrogen, flutamide, on oocyte quality and embryo development in rats superovulated with pregnant mare's serum gonadotropin. Biol Reprod 39 (1988) 279-286
4. Smith A.G. Embryo-derived stem cells. of mice and men. Annu Rev Cell Dev Biol 17 (2001) 435-462
5. Rizzino A. Embryonic stem cells provide a powerful and versatile model system. Vitam Horm 64 (2002) 1-42
6. Rohwedel J., Guan K., Hegert C., and Wobus A.M. Embryonic stem cells as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies. present state and future prospects. Toxicol In Vitro 15 (2001) 741-753
7. Wobus A.M., Holzhausen H., Jakel P., and Schoneich J. Characterization of a pluripotent stem cell line derived from a mouse embryo. Exp Cell Res 152 (1984) 212-219
8. Babinet C., and Cohen-Tannoudji M. Genome engineering via homologous recombination in mouse embryonic stem (ES) cells. an amazingly versatile tool for the study of mammalian biology. An Acad Bras Cienc 73 (2001) 365-383
9. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., and Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 97 (2000) 11307-11312
10. Ruhnke M., Ungefroren H., Zehle G., Bader M., Kremer B., and Fandrich F. Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages. Stem Cells 21 (2003) 428-436
11. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct 26 (2001) 137-148
12. Kang H.Y., Cho C.L., Huang K.L., Wang J.C., Hu Y.C., Lin H.K., et al. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res 19 (2004) 1181-1190
13. Kang H.Y., Tsai M.Y., Chang C., and Huang K.E. Mechanisms and clinical relevance of androgens and androgen receptor actions. Chang Gung Med J 26 (2003) 388-402
14. Collins L.L., Lee H.J., Chen Y.T., Chang M., Hsu H.Y., Yeh S., et al. The androgen receptor in spermatogenesis. Cytogenet Genome Res 103 (2003) 299-301
15. Wilson J.D., Griffin J.E., George F.W., and Leshin M. The role of gonadal steroids in sexual differentiation. Recent Prog Horm Res 37 (1981) 1-39
16. Wilson J.D., Griffin J.E., Leshin M., and George F.W. Role of gonadal hormones in development of the sexual phenotypes. Hum Genet 58 (1981) 78-84
17. Quigley C.A., De Bellis A., Marschke K.B., el-Awady M.K., Wilson E.M., and French F.S. Androgen receptor defects. historical, clinical, and molecular perspectives. Endocr Rev 16 (1995) 271-321
18. De Bellis A., Quigley C.A., Marschke K.B., el-Awady M.K., Lane M.V., Smith E.P., et al. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome. J Clin Endocrinol Metab 78 (1994) 513-522
19. Keller E.T., Ershler W.B., and Chang C. The androgen receptor. a mediator of diverse responses. Front Biosci 1 (1996) d59-d71
20. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95 (1998) 15677-15682
21. Lydon J.P., DeMayo F.J., Conneely O.M., and O'Malley B.W. Reproductive phenotpes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 56 (1996) 67-77
22. Ikeda Y., Shen W.H., Ingraham H.A., and Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8 (1994) 654-662
23. Huang F.J., Hsu Y.C., Kang H.Y., Chang S.Y., Hsuuw Y.D., and Huang K.E. Effects of retinoic acid on the inner cell mass in mouse blastocysts. Fertil Steril 83 (2005) 238-242
24. Kang H.Y., Huang K.E., Chang S.Y., Ma W.L., Lin W.J., and Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277 (2002) 43749-43756
25. Miura T., Mattson M.P., and Rao M.S. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3 (2004) 333-343
26. Rosenberg K.M., and Sherman G.F. Testosterone induced pup-killing behavior in the ovariectomized female rat. Physiol Behav 13 (1974) 697-699
27. Mann M.A., and Svare B. Prenatal testosterone exposure elevates maternal aggression in mice. Physiol Behav 30 (1983) 503-507
28. Fritz H., Giese K., and Suter H.P. Prenatal and postnatal development of rats following the maternal treatment with testosterone during the late period of embryogenesis. Arzneimittelforschung 34 (1984) 780-782
29. Swanson H.E., and van Werff ten Bosch J.J. Modification of male rat reproductive tract development by a single injection of testosterone propionate shortly after birth. Acta Endocrinol (Copenh) 50 (1965) 310-316
30. Gustafson O., Nylund L., and Carlstrom K. Does hyperandrogenism explain lower in vitro fertilization (IVF) success rates in smokers?. Acta Obstet Gynecol Scand 75 (1996) 149-156
31. Silva C.C., and Knight P.G. Effects of androgens, progesterone and their antagonists on the developmental competence of in vitro matured bovine oocytes. J Reprod Fertil 119 (2000) 261-269
32. Crocoll A., Zhu C.C., Cato A.C., and Blum M. Expression of androgen receptor mRNA during mouse embryogenesis. Mech Dev 72 (1998) 175-178
33. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
34. Yallampalli C., Osuamkpe C., and Nagamani M. Influence of the antiandrogen hydroxyflutamide on in vitro development of mouse embryos. J Reprod Fertil 99 (1993) 467-470
35. Lee Y.F., Lin W.J., Huang J., Messing E.M., Chan F.L., Wilding G., et al. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Cancer Res 62 (2002) 6039-6044
36. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M.K., Han K., et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8 (2002) 1153-1160
37. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8 (2002) 1145-1152
38. Lapointe J., and Labrie C. Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation. Endocrinology 142 (2001) 4331-4338